The European Union will not renew its mandatory approval system for Covid-19 vaccine exports when it expires at the end of the year, the European Commission has said.
This means that vaccine producers will no longer have to request authorisation to export vaccines outside the EU.
The export authorisation mechanism will be replaced from January 1, with a "new monitoring mechanism that will provide the Commission with timely, company-specific, vaccine export data."
The Commission said on Friday that the decision is part of the EU's effort to ensure rapid production, and wide and equitable distribution of the Covid-19 vaccines that the world urgently needs, Xinhua news agency reported.
"The EU is the biggest global provider of Covid-19 vaccines, with over 1.3 billion doses exported so far, more than half of its production," the Commission said. "The EU will also donate at least 500 million doses to the most vulnerable countries over the next few months."
The 27-nation bloc has fully vaccinated 68 per cent of its population of 445 million, and has ample stocks for booster campaigns. Such campaigns have already started in several member states.
"With new outbreaks of the virus in the EU and the risk of new variants of the Covid-19 virus, there is still a need for transparency of exports of vaccines, which the EU will continue to do under the new monitoring mechanism," the Commission emphasised.
--IANS
int/sks/skp/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)